Skip to main content
. 2018 Mar 27;18:343. doi: 10.1186/s12885-018-4236-6

Table 1.

The results of the examinations and treatment courses of the patient

Date Bone Marrow Cells Peripheral cells Treatment
Myeloblast% Dysplasia LAP WBC(X109/L) Hb(g/L) Plt(X109/L)
21/03/14 1 granulocytes 387,100% 85,N:90% 74 62 Hu
27/03/14 2.6 granulocytes NA 14, N:85% 60 29 Hu
31/03/14 25, N:89% 83 25 Hu
11/05/14 34,N:92% 62 3 Transfused
14/05/14 1.6 granulocytes 387,100% Transfused
17/05/14 53,N:92% 65 5 Transfused
19/05/14 66,N:90% 60 21 Transfused
22/05/14 67,N:92% 56 11 Transfused
25/05/14 64,N:94% 67 5 Bleeding Transfused,
26/05/14 116,N:93% 34 7 Transfused
27/05/14 90,N:85% 33 29 Died

It displayed the examinations of bone marrow and peripheral cells at the process of the diagnosis and treatment courses of the patient